BeyondSpring Pharmaceuticals, a clinical stage biopharma focused on the development of cancer therapies including a Phase III immuno-oncology compound Plinabulin, has entered into a five-year collaboration agreement with the Fred Hutchinson Cancer Research Center to develop oncology therapeutics and diagnostics in the company’s pipeline. The collaboration will be led by Eric Holland, senior vice president and director of the human biology division at Fred Hutchinson. The cancer center will pr...